Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity

3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity

US Patent 7906508 · Granted Mar 15, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fluorine-containing compound having unsaturated bond, and surface modifier using2022
Pyrimidine compound and medical use thereof2014
Azetidine compound and pharmaceutical use thereof2014
Azetidine compound and pharmaceutical use thereof2014
Triazole compounds and uses related thereto2012
Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR2011
Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR2011
Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR2011
Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR2011
Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR2011
Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR2011
Triazole compounds and uses related thereto2010